Literature DB >> 29204967

The importance of a well-structured pancreatic screening program for familial and hereditary pancreatic cancer.

Hans F A Vasen1.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29204967     DOI： 10.1007/s10689-017-0066-y

Source DB:  PubMed          Journal:  Fam Cancer        ISSN： 1389-9600            Impact factor:   2.375


× No keyword cloud information.
  19 in total

Review 1.  Familial pancreatic cancer--current knowledge.

Authors:  Detlef K Bartsch; Thomas M Gress; Peter Langer
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-06-05       Impact factor: 46.802

2.  Early diagnosis and treatment of pancreatic dysplasia in patients with a family history of pancreatic cancer.

Authors:  T A Brentnall; M P Bronner; D R Byrd; R C Haggitt; M B Kimmey
Journal:  Ann Intern Med       Date:  1999-08-17       Impact factor: 25.391

3.  Frequent detection of pancreatic lesions in asymptomatic high-risk individuals.

Authors:  Marcia Irene Canto; Ralph H Hruban; Elliot K Fishman; Ihab R Kamel; Richard Schulick; Zhe Zhang; Mark Topazian; Naoki Takahashi; Joel Fletcher; Gloria Petersen; Alison P Klein; Jennifer Axilbund; Constance Griffin; Sapna Syngal; John R Saltzman; Koenraad J Mortele; Jeffrey Lee; Eric Tamm; Raghunandan Vikram; Priya Bhosale; Daniel Margolis; James Farrell; Michael Goggins
Journal:  Gastroenterology       Date:  2012-01-12       Impact factor: 22.682

4.  Cancer risks in BRCA2 families: estimates for sites other than breast and ovary.

Authors:  C J van Asperen; R M Brohet; E J Meijers-Heijboer; N Hoogerbrugge; S Verhoef; H F A Vasen; M G E M Ausems; F H Menko; E B Gomez Garcia; J G M Klijn; F B L Hogervorst; J C van Houwelingen; L J van't Veer; M A Rookus; F E van Leeuwen
Journal:  J Med Genet       Date:  2005-09       Impact factor: 6.318

5.  Cancer risks in BRCA2 mutation carriers.

Authors: 
Journal:  J Natl Cancer Inst       Date:  1999-08-04       Impact factor: 13.506

6.  Cancer Incidence in BRCA1 mutation carriers.

Authors:  Deborah Thompson; Douglas F Easton
Journal:  J Natl Cancer Inst       Date:  2002-09-18       Impact factor: 13.506

7.  Five years of prospective screening of high-risk individuals from families with familial pancreatic cancer.

Authors:  P Langer; P H Kann; V Fendrich; N Habbe; M Schneider; M Sina; E P Slater; J T Heverhagen; T M Gress; M Rothmund; D K Bartsch
Journal:  Gut       Date:  2009-05-25       Impact factor: 23.059

8.  Benefit of Surveillance for Pancreatic Cancer in High-Risk Individuals: Outcome of Long-Term Prospective Follow-Up Studies From Three European Expert Centers.

Authors:  Hans Vasen; Isaura Ibrahim; Carmen Guillen Ponce; Emily P Slater; Elvira Matthäi; Alfredo Carrato; Julie Earl; Kristin Robbers; Anneke M van Mil; Thomas Potjer; Bert A Bonsing; Wouter H de Vos Tot Nederveen Cappel; Wilma Bergman; Martin Wasser; Hans Morreau; Günter Klöppel; Christoph Schicker; Martin Steinkamp; Jens Figiel; Irene Esposito; Evelina Mocci; Enrique Vazquez-Sequeiros; Alfonso Sanjuanbenito; Maria Muñoz-Beltran; José Montans; Peter Langer; Volker Fendrich; Detlef K Bartsch
Journal:  J Clin Oncol       Date:  2016-04-25       Impact factor: 44.544

9.  Increased risk of cancer other than melanoma in CDKN2A founder mutation (p16-Leiden)-positive melanoma families.

Authors:  Femke A de Snoo; D Timothy Bishop; Wilma Bergman; Inge van Leeuwen; Clasine van der Drift; Frans A van Nieuwpoort; Coby J Out-Luiting; Hans F Vasen; Jeanet A C ter Huurne; Rune R Frants; Rein Willemze; Martijn H Breuning; Nelleke A Gruis
Journal:  Clin Cancer Res       Date:  2008-11-01       Impact factor: 12.531

10.  Prevalence of germ-line mutations in cancer genes among pancreatic cancer patients with a positive family history.

Authors:  Kari G Chaffee; Ann L Oberg; Robert R McWilliams; Neil Majithia; Brian A Allen; John Kidd; Nanda Singh; Anne-Renee Hartman; Richard J Wenstrup; Gloria M Petersen
Journal:  Genet Med       Date:  2017-07-20       Impact factor: 8.822
View more
  3 in total

1.  Quality of life impact of EUS in patients at risk for developing pancreatic cancer.

Authors:  Irina M Cazacu; Adriana A Luzuriaga Chavez; Tito R Mendoza; Wei Qiao; Ben S Singh; Raza H Bokhari; Adrian Saftoiu; Jeffrey H Lee; Brian Weston; John R Stroehlein; Michael P Kim; Matthew H G Katz; Anirban Maitra; Florencia McAllister; Manoop S Bhutani
Journal:  Endosc Ultrasound       Date:  2020 Jan-Feb       Impact factor: 5.628

Review 2.  Psychological impact of pancreatic cancer screening by EUS or magnetic resonance imaging in high-risk individuals: A systematic review.

Authors:  Irina Mihaela Cazacu; Adriana Alexandra Luzuriaga Chavez; Adrian Saftoiu; Manoop S Bhutani
Journal:  Endosc Ultrasound       Date:  2019 Jan-Feb       Impact factor: 5.628

3.  A comprehensive analysis of candidate genes in familial pancreatic cancer families reveals a high frequency of potentially pathogenic germline variants.

Authors:  Julie Earl; Cristina Galindo-Pumariño; Jessica Encinas; Emma Barreto; Maria E Castillo; Vanessa Pachón; Reyes Ferreiro; Mercedes Rodríguez-Garrote; Silvia González-Martínez; Teresa Ramon Y Cajal; Luis Robles Diaz; Isabel Chirivella-Gonzalez; Montse Rodriguez; Eva Martínez de Castro; David García-Seisdedos; Gloria Muñoz; Juan Manuel Rosa Rosa; Mirari Marquez; Nuría Malats; Alfredo Carrato
Journal:  EBioMedicine       Date:  2020-02-27       Impact factor: 8.143
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.